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ABSTRACT
This paper introduces a newly developed method of applying liquid chromatography- tandem mass spectrometry (LC/MS/MS) to
the analysis of aristolochic acids (AAs) in Chinese herbal (medicinal) preparations. Sensitive and highly accurate readings were
obtained for this study using both a photodiode array (PDA) detector and tandem mass spectrometer. The following optimized conditions for LC/MS/MS were set for this study: Separation was accomplished using a reverse phase C18 column (2.1 × 150 mm, 5 µm).
The mobile phase comprised 35% acetonitrile and a 65% aqueous solution containing 0.1% formic acid and 0.1% ammonium acetate at
a flow rate of 0.3 mL/min with a split ratio of 1:1 into the PDA detector and the tandem mass spectrometer. MS/MS qualitative
analysis was performed at 3.0 kV capillary voltage, with a collision energy level for aristolochic acid I (AA-I) of 10 eV and for aristolochic acid II (AA-II) of 12eV. The electrospray ionization source was operated in the positive mode. AA-I [M + NH4]+ ions at m/z
359 and AA-II [M + NH4]+ ions at m/z 329 were selected as precursor ions for daughter ion scanning. The characteristic daughter ion
mass spectra for AA-I and AA-II were generated and studied carefully. Quantification of results was done using the multiple reaction
monitoring (MRM) method. The [M + NH4]+ and [(M + NH4)- NH3-CO2]+ ions of both AA-I and AA-II were selected as precursor
and daughter ions for the MRM analysis. MS/MS detection limits were defined as 2.0 ng/mL of AA-I, and 2.8 ng/mL of AA-II. The
linear regression correlation coefficients of the calibration cure were 0.9992 of AA-I within the range of 0.02~16.00 µg/mL and 0.9988
of AA-II within the range of 0.028~22.40 µg/mL. Relative standard deviations of 0.73% and 10.44% for AA-I, and 1.38% and 6.10%
for AA-II were determined for the intraday and interday tests. Recoveries for five differing concentrations of AA-I ranged from 99.0%
to 106.9% and, for five differing concentrations of AA-II, ranged from 92.0% to 104.5%. Levels of AA-I and AA-II detected in the 12
commercial Chinese medicinal preparation samples ranged from 11.1 to 3376.0 µg/g and from 5.4 to 725.4 µg/g, respectively.
Key words: liquid chromatography- tandem mass spectrometry (LC/MS/MS), aristolochic acid, piromidic acid, electrospray, multiple
reaction monitoring (MRM)

INTRODUCTION
Aristolochic acids, a group of structurally analogous
nitrophenanthrene derivative compounds(1) , are found
primarily in plants of the species Aristolochia and
Asarum(2). The group’s nephrotoxic and carcinogenic properties have earned for aristolochic acids increasing international attention. For example, several cases reported in the
literature discussing patients experiencing end-stage renal
failure following ingestion of Chinese herbal weight loss
preparations containing AAs(3-7) noted not only induced
renal interstitial fibrosis but also the development of upper
urothelial malignancies in some patients, with aristolochic
acid-related DNA adducts found in tissue samples(8). Some
aristolochic acid-containing plants of the species
Aristolochia (e.g., A. fanchi, A. manshuriensis, A. debil)
and Asarum (e.g., A. canadese and A. caudatum)(2) find
their way regularly into traditional Chinese medicine preparations. The similar vernacular names (in Chinese) of these
* Author for correspondence. Tel: +886-2-26531239;
Fax: +886-2-26531244; E-mail: linjerhuei@nlfd.gov.tw

plants to other, non-AA containing medicinal plants make
the risk of inadvertent use in medicinal preparations significant. For example, the name “fangchi” in Chinese is
commonly used to refer to plants belonging to a variety of
species. One, called “kuanfangchi” in Chinese, is an aristolochic acid-containing plant of the species A. fanchi. It
bears a close resemblance to “fenfangchi,” a plant of the
species Stephania tetratra that does not contain AAs. To
minimize the risk posed by improper use of AA-containing
plants in Chinese medicinal preparations and the potential
for subsequent serious adverse effects on consumers, our
laboratory began, at the request of the Committee on
Chinese Medicine and Pharmacy (CCMP, Taiwan’s
oversight authority for Chinese medicine), a series of
studies on analytical methods that employ TLC(9) and
HPLC to detect the presence of AAs in 15 Chinese plant
medicinal preparations. Each medicinal preparation
selected for this study is governed by an officially determined and enforced formula. Recognizing the high risk
that long-term use of AAs pose to health, the CCMP
imposed in 2003 a comprehensive ban on the use of AA-

126
Journal of Food and Drug Analysis, Vol. 13, No. 2, 2005

containing plants of the genus Aristolochia and on sale of
associated herbal preparations.
Several analytical methods employing TLC (10-12),
LC/UV(13-15), and LC/MS(11,12) have been published in the
literature. As traditional Chinese herbal preparations
typically comprise multiple components blended together
according to complex formulae, any analytical method
selected must both permit precise separation of components
in order to remove interference from target compounds and
deliver sensitive and selective detection to maximize target
compound identification. A problem with the TLC method
is the lack of a detection method for follow-on confirmation
once suspected compounds have been identified. The
LC/UV method detects only AA levels above a certain
level. An extended chromatographic separation time, more
sophisticated mobile phase system, or other auxiliary
method such as standard addition might be introduced to
solve problems caused by elevated interference levels. In
this paper, we introduce our experience using a combined
LC/MS/MS method. This method delivered improved
analysis results by combining LC separation and two types
of detecting techniques (ultraviolet spectrometry and
MS/MS spectrometry).

MATERIALS AND METHODS
I. Materials
A mixture containing 40% of AA-I and 56% of AA-II
was purchased from Sigma Co. (St. Louis, USA) (lot no.
092K1249) and used as the standard. Piromidic acid,
purchased from ICN Biomedicals Inc., was used as the
internal standard. HPLC grade methanol and reagent grade
formic acid were purchased from Ridel-deHaën (Seelze,
Germany). HPLC grade acetonitrile was purchased from
Labscan Co., Ltd. (Bangkok, Thailand). Reagent grade
ammonium acetate was purchased from Merck (Germany).
Test samples included 12 commercially available Chinese
herbal medicinal preparations obtained from retail outlets in
Taiwan. Each of the samples was under suspicion of AA
contamination based on preliminary TLC screening results.
Five species of plants, including Radix Glycyrrizae, White
Atractylodes Rhizome, Radix Hedysari, Rhizoma
Zingiberis, and Fructus jujube, were randomly selected
from those plant samples submitted by pharmaceutical
companies as part of their product registration process.
These were used for the preparation of the blank sample for
use in the recovery test study.
II. Instruments and Experiment
(I) LC/MS/MS condition
Analyses were carried out using a high performance
liquid chromatograph (Waters 2690 Alliance) interfaced to
a quadrupole mass spectrometer (Micromass Quattro

Ultima) through a PEEK loop via a photodiode array
detector (Waters 996) with the split ratio adjusted to 1:1.
Chromatographic separation was performed on a C18
column (Zorbax Extend-C18, 150 × 2.1 mm i.d., 5µm)
under an isocratic elution of a mixed solvent system (pH
3.62) in a composition of 35% acetonitrile and 65%
aqueous solution containing 0.1% ammonium acetate and
0.1% formic acid at a flow rate of 0.3 mL/min. A full UV
spectrum was scanned from 200 to 350 nm and UV spectra
obtained from analyses of standard AA-I and AA-II were
recorded for reference. The chromatographic resolution (R)
between AA-I and AA-II was calculated by dividing the
difference in retention time by half the sum of baseline
peak widths.
The mass spectrometer was fitted with an electrospray
(ES) ionization source, which was operated in positive
mode. Nitrogen served as both the desolvation and cone
gas, with flow rates adjusted to 600 L/hr and 60 L/hr,
respectively. Argon gas was employed in the collisioninduced dissociation process. Source and desolvation temperatures were set to 120˚C and 350˚C, respectively. The
range for the full ESI scan was set from 100 to 800 in m/z,
and the range for a daughter ion scan was set from 200 to
400 in m/z. Data was acquired through multiple cumulating
analysis (MCA). Qualitative analysis was carried out in
daughter ion scan mode. m/z 359 and m/z 329 ions were
selected as the precursor ions for AA-I and AA-II, respectively. Parameters involved with the MS/MS analysis such
as capillary voltage, cone voltage, collision energy, etc.
were optimized by a tuning procedure that directly and continually injected a concentration of 5 µg/mL of the AA
standard into the ion source through a syringe pump (BAS
BeeTM) at 10 µL/min. The optimized capillary voltage was
3.0 kV and the optimized cone voltage was 20 V. Collision
energy for AA-I was 10 eV and that for AA-II was 12 eV.
Quantification was performed in multiple reaction monitoring (MRM) mode. The pairs of ions selected as precursor
and daughter ions were m/z 359 and m/z 298 for AA-I, m/z
329 and m/z 268 for AA-II, and m/z 289 and m/z 271 for
the piromidic acid, used as the internal standard. The cone
voltage and the collision energy set for piromidic acid were
40 volts and 20 eV. Dwelling time within each monitoring
channel was 0.25 sec. The full mass spectrum and the
daughter ion spectrum obtained from the analysis of AA
standards were appended to the library for reference (see
Figures 1, 2 and 3).
(II) Preparation of standard solutions and the calibration
curve
An accurately weighed amount of 5 mg of AAs was
dissolved in 70% methanol in a 100 mL volumetric flask.
The solution was diluted with 70% methanol to give
standard solutions for calibration curves in the range of
0.02~16.00 µg/mL of AA-I and 0.028~22.40 µg/mL of AAII (n = 7). Piromidic acid was added as the internal
standard to attain a final concentration of 0.1 µg/mL in
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Figure 1. A full mass spectrum of AA-I from m/z 100 to m/z 800,
showing considerable intensity of [M + NH4]+ ions at m/z 359.
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Figure 2. A full mass spectrum of AA-II from m/z 100 to m/z 800,
showing considerable intensity of [M + NH4]+ ions at m/z 329.
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of AA-I and AA-II was within the detection range of the calibration curves. Piromidic acid was added to each sample as
the internal standard, giving a final concentration of 0.1
µg/mL. The injection volume was 20 µL. Qualitative analysis employing LC/MS/MS was carried out following the
method described in section II. (I). Both the ultraviolet
absorptive spectrum and daughter ion spectrum obtained
from samples were compared against AA-I and AA-II reference spectra. The matching quality of the background subtracted daughter ion spectra between samples and the standard must be more than 80%. Further quantification of the
AAs in each sample was carried out by MRM analysis, as
described in section II. (I), once the presence of the AAs was
confirmed. The quantities of AA-I and AA-II in each sample
were calculated based on their calibration curves.
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Figure 3. Daughter ion spectra of the ammonia additive precursor
ions of (A) AA-I at m/z 359 and (B) AA-II at m/z 329. Distinctive
fragments of de-carbon dioxide molecular ions of AA-I and AA-II
were observed at m/z 398 and m/z 268, respectively.

each solution. A volume of 20 µL was injected and
analyzed by LC/MS/MS with parameters described in
section II. (I). Quantification was done using the MRM
method and the calibration curve was obtained by plotting
concentration versus peak area ratio of standard to internal
standard. The linear regression equation and its correlation
coefficient (r) were then calculated.
(III) Sample preparation and determination
An amount of 5 g of the samples was accurately measured and extracted with 50 mL of 70% methanol under sonication for 30 min. After filtration, 70% methanol was added
to the filtrate to make the solution volume exactly 50 mL.
The solution was further diluted until the final concentration

A volume of 20 µL of the standard solution containing
0.1 µg/mL internal standard was injected six times into the
LC/MS/MS over a one day period and three times each day
for 5 consecutive days. Following the method described in
section II. (I), MRM analysis was performed to assess the
repeatability of the analysis in LC/MS/MS. Standard deviation and relative standard deviation of the peak area ratio of
the standard to internal standard were then calculated.
(VI) Recovery test
Five differing quantities of AAs were added into a
blank sample to evaluate the recoverability of MRM
analysis of LC/MS/MS. The blank sample was prepared
with plant materials described in section I. Referencing
dosage information specified in the official formula for
“Fang-Jii-Hwang-Chi-Tang” published by the CCMT (see
table 1), a one-day dose of each of the plant-based ingredients in the formula, with the exception of “fangchi” (Radix
Stephaniae Tetrandrae), were accurately weighed and
extracted using 70% MeOH under sonication. Five
different amounts of AAs were then introduced into the
extract to let the final concentrations in each spiked
solution attain 0.2, 0.4, 0.8, 4, and 8 µg/mL of AA-I; 0.28,
0.56, 1.12, 5.6, and 11.2 µg/mL of AA-II; and 0.1 µg/mL of
piromidic acid as the internal standard. Following the
MRM method described in section II. (I), analyses of AA-I,
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Table 1. Official formula for “Fang-Jii-Hwang-Chi-Tang” (published by CCMT)
Ingredient
Processed Radix
White Atractylodes
Radix
Glycyrrizae
Rhizome
Hedysari
One-day dose (g)
3.0
4.5
6.0

Rhizoma
Zingiberis
4.0

Fructus
jujube
1.0

2: Diode Array
Tic
6.53e6

9.28

100 (A)

12.62

%

Radix Stephaniae
Tetrandrae
6.0

AA II
AA I

0
100

1: MRM of 3 Channels ES+
359.1 > 298
1.24e7

12.42

(B)
AA I: 359 > 298

%
0
100

1: MRM of 3 Channels ES+
329.1 > 268
4.93e6

9.14

(C)
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%
0
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1: MRM of 3 Channels ES+
TIC
1.25e7
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Figure 4. Chromatograms of AAs in the standard solution determined by LC/MS/MS. (A) Chromatogram of AAs detected by PDA; (B) MRM
chromatogram of AA-I from m/z 359 to m/z 298; (C) MRM chromatogram of AA-II from m/z 329 to m/z 268; and (D) combined MRM chromatogram of AA-I, AA-II and piromidic acid.

and of AA-II in each spiked sample were done a total of
three times. Recoveries of AA-I and AA-II were separately
calculated using their calibration curves.

RESULTS AND DISCUSSION
Separating AA-I and AA-II under liquid chromatography as described in the above text is a simple operation.
The two components were eluted out quickly, in approximately 12.4 min (for AA-I) and 9.1 min (for AA-II).
Resolution attained 2.47. Both showed good peak shapes
(Figure 4). Suitable addition of formic acid into the mobile
phase to adjust the pH condition to a reasonable acidic state
was successful in promoting resolution as a result of
sharpened peaks. Avoiding tailing and broadening by
inhibiting AA-I and AA-II from dissociation was possible
because both were carboxylic compounds (Figures 1 and 2)
According to a study by Simmonds(16), the ideal ionization condition for AAs is atmospheric pressure chemical
ionization (APCI) in the positive mode, including
ammonium ions in the mobile phase. While two precursor
ions, protonated ions ([M + H]+) and ammoniated ions ([M
+ NH4]+) can be generated, a significant further enhancement of [M + NH4]+ ion currents occurs when either 0.1%

ammonium acetate is added to the aqueous solvent (pH 7.4)
or a constant infusion of 10% aqueous ammonia solution
post-column is made, with the aid of a syringe pump.
As an alternative to the ion trap mass spectrometer
utilized by Simmonds, we conducted a trial of the ESI+
source by combining it with 0.1% ammonium acetate and a
formic acid-containing mobile system and then operating it
on a quadrupole mass spectrometer. A very intense peak of
[M + NH4]+ AA-I ions at m/z 359 and AA-II ions at m/z
329 was observed in the full mass scan (Figures 1 and 2 ).
This demonstrated the efficiency of the ionization and the
applicability of the chosen precursor ions ([M + NH4]+) in
this MS/MS analysis. Dimmers such as [2M + NH4]+ or
[2M + Na] + also appeared in the full mass scan.
Characteristic daughter ion spectra resulting from the
collision-induced dissociation (CID) of AA-I and AA-II
were observed under optimal experiment conditions. Both
AA-I and AA-II exhibit unique daughter ion spectra (Figure
3), with a considerable intensity of [(M + NH4) – NH3 –
44]+ ions, [(M + NH4) – NH3– 18]+ ions, and [M + H]+
ions. [(M + NH4) – NH3– 44]+ ions, at m/z 298 for AA-I
and m/z 268 for AA-II, appeared to be most prominent and
demonstrated stability under repeated analysis. They could
result from the loss of a carbon dioxide molecule in the
structures and play an important role in the identification of
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AAs. [M + H]+ and [(M + NH4) – NH3– 18]+ ions were
observed frequently in the MS/MS analysis, due to the loss,
respectively, of one ammonia and one water molecule.
Therefore, neither would be particularly useful in structure
diagnosis. A strategy of having the most abundant target
precursor ions occur and generating the most diagnostic
daughter ions was applied in the optimization of the
MS/MS condition.
Calibration curves, obtained through MRM analysis,
of serial standard solutions whose concentrations were in
the range of 0.05 to 40 µg/mL (corresponding to
0.02~16.00 µg/mL of AA-I and 0.028~22.40 µg/mL of
AA-II) showed a positive linear relationship between concentrations and relative measured values. Linear regression
equations and their correlation coefficients were:
y = 0.4223x – 0.0749 (r = 0.9992) for AA-I; y =
0.0983x – 0.0311 (r = 0.9988) for AA-II.
Detection limits for AA-I and AA-II were determined
under an MRM analysis of AAs standards and were determined as 2.0 ng/mL for AA-I and 2.8 ng/mL for AA-II.
These values demonstrate the high sensitivity of the
LC/MS/MS method.
The level of precision achievable by the LC/MS/MS
method was assessed by repeated injections six times in one
day and three times each day over a five day period. The
result (described in Table 2) suggested excellent repeatability of the intraday test, while detecting slight determined
deviations in interday test. Slight variations in instrumentcontrolled variables such as desolvation gas flow and cone
gas flow were observed after operation repetition over a
period of days. This may have influenced inter-day results,
as the tandem mass spectrometer provides highly sensitive
readings. Even with these potentially influential factors,
the accuracy and reliability of results should be acceptable.
Five different concentrations of AA-I (0.2, 0.4, 0.8, 4,
8 µg/mL) and of AA-II (0.28, 0.56, 1.12, 5.6, 11.2 µg/mL)
were examined in the recovery study. The results determined for AA-I, ranging from 99.0% to 106.9%, and for
AA-II, ranging from 92.0% to 104.5% (Table 3), suggest
that an acceptable level of accuracy is achieved by the
developed MRM quantitative method.

This study tested 12 samples of traditional medicinal
preparations for AA-I and AA-II, with qualitative and quantitative test results shown in Table 4. Levels detected
ranged from 11.1 to 3376.0 µg/g for AA-I and from 5.4 to
725.4 µg/g for AA-II. The LC/MS/MS method described
in this study demonstrated superior sensitivity, specificity
and selectivity over conventional TLC and HPLC methods.
AA-I and AA-II exhibited typical UV spectra, with
maximum absorption at 224, 250, 321 nm and 217, 251,
301 nm, respectively. Characteristic mass spectra showing
prominent fragments at m/z 298 for AA-I and m/z 268 for
AA-II (due to CO 2 loss in the AA structure) are also
available for full daughter ion spectral comparison. These
two types of spectra contribute to greater specificity in
detecting AAs in plant (herbal) preparations. Compounds
with the same mass-to-charge ratio were allowed to pass
Table 2. Relative standard deviations for intraday and interday
analyses of AA-I and AA-II
Peak area ratio of std. to internal std.
Compound
[Mean ± SD (RSD%)]
Intradaya
Interdayb
AA-I
1.56 ± 0.01 (0.73)
9.82 ± 1.02 (10.44)
AA-II
0.43 ± 0.006 (1.38)
3.06 ± 0.19 (6.10)
a
n = 6.
b
n = 15, 3 injections daily for 5 consecutive days.

Table 3. Recoveries of AA-I and AA-II in the spiked sample
Compound
Spiked concentration
Recovery (%)
(µg/mL)
Mean ± SD (RSD%)a
AA-I
0.2
101.1 ± 4.45 (4.40)
0.4
100.0 ± 1.77 (1.77)
0.8
103.3 ± 2.87 (2.77)
4.0
106.9 ± 2.66 (2.49)
8.0
99.0 ± 3.25 (3.28)
AA-II
0.28
104.5 ± 2.33 (2.23)
0.56
96.5 ± 4.41 (4.57)
1.12
95.7 ± 4.28 (4.47)
5.6
92.0 ± 1.43 (1.55)
11.2
98.6 ± 3.93 (3.99)
a
n = 3.

Table 4. Levels of AA-I and AA-II detected in 12 commercial Chinese herbal prescriptions by MRM of LC/MS/MS
No.
Form of dosage
Labeled plants
Detecting results
Amounts of
AA-I
AA-II
AA-I (µg/g)
1
Traditional pill
Mutong
+
+
11.1
2
Traditional powder
Mutong
+
+
27.4
3
Traditional powder
Mutong
+
+
201.9
4
Traditional pill
Mutong
+
+
101.1
5
Concentrated granules
Fangji
+
+
2724.5
6
Traditional powder
+
+
66.5
7
Concentrated granules
Mutong
+
+
3376.0
8
Concentrated powder
Mutong
+
+
101.8
9
Concentrated granules
Madolin
+
+
297.9
10
Traditional pill
Mutong
+
+
79.8
11
Traditional pill
Mutong
+
+
41.0
12
Traditional pill
Madolin
+
+
26.1

Amounts
of AA-II (µg/g)
5.4
24.0
54.3
34.1
200.1
34.7
725.4
37.7
43.5
31.5
25.8
8.8
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Figure 5. Chromatograms showing the analytical result of AAs in one of the 12 samples of Chinese herbal preparations by LC/MS/MS. (A)
Chromatogram detected by PDA; (B) MRM chromatogram of AA-I; (C) MRM chromatogram of AA-II; (D) combined MRM chromatogram of
AA-I, AA-II, and piromidic acid in the sample; (E) TIC of the daughter ion scan for the ammonia additive precursor ions of AA-II in the
sample; and (F) TIC of the daughter ion scan for the ammonia additive precursor ions of AA-I in the sample.
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through the first MS analyzer and undergo “collision
induced dissociation” (CID), which generated characteristic
daughter ions for detection by the second MS analyzer.
This technique helped reduce interference from the coeluting compounds in the sample matrix.
Figure 5 reproduces the LC/MS/MS chromatogram for
sample no. 9 in Table 4. While UV signals indicating AA-I
or AA-II barely register in Figure 5(A), a distinct mass
message for AA-I and AA-II occurs in Figure 5(B) and (C)
under MRM analysis. This shows the great difference in
sensitivity between PDA detectors and tandem mass spectrometers. The enhanced sensitivity of the developed
LC/MS/MS method improves AA detection capabilities significantly. Figure 5(E) and (F), respectively, display the
total ion chromatogram (TIC) of the daughter ion scans for
AA-I and AA-II. Although there were unclear signals of
AA-II in Figure 5(E), its daughter ion mass spectrum,
obtained after background subtraction, was capable of high
matching quality with the AA-II reference spectrum. The
developed LC/MS/MS method can also resolve problems
common to TLC or LC/UV analyses related to limited LOD
and interference from co-eluting compounds. This method
also allows easy preparation of samples, with no clean up,
purification or concentration required.
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